Thank you to Dr. Meryl Nass, dated February 27, 2021.
Yesterday, Feb 26, the FDA’s vaccine advisory committee (VRBPAC), an FDA committee called Vaccines and Related Biological Products Advisory Committee, met to give its assent to the third Covid vaccine candidate applying for an Emergency Use Authorization (EUA). And I spent another day listening in. FDA is expected to authorize use of the vaccine today.
This one requires only one dose. For now. The company is doing a clinical trial of two doses and they could be recommended in future. The VRBPAC committee comments were lackluster. The members had little to go on. There is no adenovirus vaccine in civilian use in the US, just as there were no mRNA vaccines. The committee members simply don’t know what they have to watch out for. One admitted it, and asked if FDA would assist and suggest what types of issues the newly licensed Ebola adenovirus vaccine or the military adenovirus vaccine had faced. FDA responded with stony silence. Clearly this “advisory” meeting was only needed for its rubber stamp.
Most of the sponsor’s (Johnson and Johnson) presenters were from the Janssen division, based in Belgium. Many of the FDA’s presenters were non-native English speakers. The combination of an audio transmission that kept dropping out, and inability to catch many of the words made it a challenge to fully grasp the presentations. Was this intended?
This here, is it by will or an omission? Yeah, that's what I thought . . . .
FDA has refused to inspect the Covid vaccine manufacturing plants before they are “authorized” under EUA. I suspect FDA administrators were directed not to slow the warp speed down.
FDA will have to inspect the factories by law before Covid vaccines are fully licensed, but it seems that the game plan is to get the country vaccinated before adequate data become available and licensure can take place.
Wait, is she saying that the lack of data is precisely the thing that allows the vax manufacturers to have an emergency permission?
Okay, here is the motherload
While Johnson and Johnson’s Janssen division designed and tested this new adenovirus vectored spike protein vaccine, the vaccine is actually being produced in a factory newly taken out of mothballs, with hundreds of new employees, that has never before produced a vaccine for mass use. It is owned by Emergent BioSolutions, a company notorious for poisoning soldiers with its anthrax vaccine, which has failed multiple anthrax vaccine inspections. On Emergent BioSolutions’ board is Kathryn Zoon, a former head of FDA’s Center for Biologics, which regulates vaccines.
Here is a vague report. This was interesting. Turns out that the vaccine that a company will run in a trial may not be the same vaccine that gets made and distributed to the public. Wow, we all are making way too many assumptions when it comes to how vaccines are made, their testing, distribution, and so forth. We're all focused on their efficacy only to find ourselves in a
This factory’s vaccine may not be exactly the same vaccine that about 20,000 subjects in the clinical trial have received. Usually vaccines for clinical trials are made in a pilot plant under stringent conditions.
So many questions about the vaccines, where it was made, is the company reputable, do they have major lawsuits against previously deadly vaccines, etc.? So none of these questions are asked let alone addressed.
Does the vaccine work? The vaccine is said to be 66% effective against moderate to severe disease in the trials, and 100% protective against death.
Okay, well, according to Fauci, where most of America got its reports on the vaccines, the vaccines started out at 95% effective and went downhill from there.
In the clinical trials, having a headache and a cough was enough to put subjects in the “moderate to severe” category. Like the two mRNA vaccines, the vaccine sponsors apparently did not see fit to test whether their vaccines block infection and transmission in humans. This is the fault of the FDA, which sets the standard for the data needed to obtain an EUA.
You can find the below video here along with a few remarks by Deborah Birx, who admitted that the vaccines were not going to work. Imagine that. While Birx is telling the truth in a rare moment, Dr. Fauci doubled down on his "effective" narrative. Even recently on the Stephen Colbert Show he praised the vaccines again, while giving a thumbs down to Hydroxychloroquine and warning people that Ivermectin was dangerous. Ha!
Apparently in the J&J trials, only a subset of participants were evaluated for side effects, "Only a subset of the subjects in the trials were evaluated for side effects. Why was that?" See what Dr. Meryl Nass said about the vaccines in general,
I can’t tell if this vaccine is safe and I doubt anyone else can, either. Nor do I want to be injected with something manufactured by the anthrax vaccine manufacturer, famed for injuring thousands of soldiers twenty years ago, while making 300% profit margins.
Read Dr. Meryl Nass's background here. She's amazing.
Meryl Nass, M.D., ABIM, is an internist with special interests in vaccine-induced illnesses, chronic fatigue syndrome, Gulf War illness, fibromyalgia and toxicology. As a biological warfare epidemiologist, she investigated world's largest anthrax epizootic in Zimbabwe, and developed a model for analyzing epidemics to assess whether they are natural or man-made. Continue reading . . .
